Keywords: pfizer, suspends, sales, bextra, uk, drug, giant

Pfizer suspends sales of Bextra in the UK

Article | 25 April 2005

US drug giant Pfizer says that it has agreed to voluntarily suspend sales and marketing of its COX-2 inhibitor Bextra ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in